Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I First Time in Human Open Label Study of GSK3745417 Administered With and Without Anticancer Agents in Participants With Advanced Solid Tumors

NCT03843359 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03843359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I First Time in Human Open Label Study of GSK3745417 Administered With and Without Anticancer Agents in Participants With Advanced Solid Tumors
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Terminated
Start date
March 12, 2019
Completion date
January 9, 2026
Enrollment
97 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms